Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Establishment Labs Holdings (ESTA) Depreciation and Depletion (2018 - 2022)

Establishment Labs Holdings' quarterly Depreciation and Depletion came in at $24000.0 in Q2 2022, down 25.0% year-on-year from $32000.0 in Q2 2021, and down 4.0% quarter-over-quarter from $25000.0 in Q1 2022.

Establishment Labs Holdings has reported Depreciation and Depletion for 5 years, with the latest figure at $24000.0 in Q2 2022.

  • For the quarter ending Q2 2022, Depreciation and Depletion fell 25.0% year-over-year to $24000.0; the trailing twelve-month figure through Jun 2022 stood at $111000.0 (down 4.31% YoY), and the FY2019 full-year result was $84000.0, down 6.56% from the prior year.
  • Depreciation and Depletion for Q2 2022 stood at $24000.0, down from $25000.0 in the prior quarter.
  • The five-year high for Depreciation and Depletion was $43000.0 in Q1 2021, with the low at $20000.0 in Q1 2020.
  • Average Depreciation and Depletion over 5 years is $24306.2, with a median of $21000.0 recorded in 2018.
  • Year-over-year, Depreciation and Depletion soared 115.0% in 2021 and slumped 41.86% in 2022.
  • Tracing ESTA's Depreciation and Depletion over 5 years: stood at $20900.0 in 2018, then gained by 0.48% to $21000.0 in 2019, then declined by 4.76% to $20000.0 in 2020, then soared by 50.0% to $30000.0 in 2021, then declined by 20.0% to $24000.0 in 2022.
  • The last three Depreciation and Depletion figures came in at $24000.0 (Q2 2022), $25000.0 (Q1 2022), and $30000.0 (Q3 2021), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation and Depletion (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 381.00 Mn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 120.00 Mn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 308.00 Mn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 29.00 Mn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 78.00 Mn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 Establishment Labs Holdings 2.04 Bn 1.97 Bn 42.34 Mn -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2022 24,000.00
Jun 30, 2022 24,000.00
Mar 31, 2022 25,000.00
Mar 31, 2022 25,000.00
Sep 30, 2021 30,000.00
Sep 30, 2021 30,000.00
Jun 30, 2021 32,000.00
Jun 30, 2021 32,000.00
Mar 31, 2021 43,000.00
Mar 31, 2021 43,000.00
Sep 30, 2020 20,000.00
Sep 30, 2020 20,000.00
Jun 30, 2020 21,000.00
Jun 30, 2020 21,000.00
Mar 31, 2020 20,000.00
Mar 31, 2020 20,000.00
Dec 31, 2019 21,000.00
Dec 31, 2019 21,000.00
Sep 30, 2019 21,000.00
Sep 30, 2019 21,000.00
Jun 30, 2019 21,000.00
Jun 30, 2019 21,000.00
Mar 31, 2019 21,000.00
Mar 31, 2019 21,000.00
Dec 31, 2018 20,900.00
Dec 31, 2018 20,900.00
Sep 30, 2018 21,000.00
Sep 30, 2018 21,000.00
Jun 30, 2018 24,000.00
Jun 30, 2018 24,000.00
Mar 31, 2018 24,000.00
Mar 31, 2018 24,000.00